Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.50
-0.39 (-2.84%)
Apr 25, 2025, 9:59 AM EDT - Market open
Benitec Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
344.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | - | - | - |
Jun 30, 2023 | 75.00K | 2.00K | 2.74% |
Jun 30, 2022 | 73.00K | 14.00K | 23.73% |
Jun 30, 2021 | 59.00K | -43.00K | -42.16% |
Jun 30, 2020 | 102.00K | -12.10M | -99.16% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
BNTC News
- 9 days ago - Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
- 4 weeks ago - Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewsWire
- 2 months ago - Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 5 months ago - Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 5 months ago - Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 6 months ago - Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewsWire
- 6 months ago - Benitec Biopharma: OPMD Program Continues To Advance With Catalysts - Seeking Alpha
- 6 months ago - Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewsWire